Activity-based protein profiling (ABPP) of various cancer cells has identified MAGL overexpression as the key metabolic switch orchestrating cancer cell malignancy by redirecting lipids from storage sites towards biosynthesis of cancer promoting signalling lipids such as eicosanoids and lysophospholipids (Nomura et al. 2010). Here, MGLL is linked to cancer.